Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Oct 12, 2026 · Filed Oct 26, 2026
Exozymes's Chief Commercial Officer sold $19K of Exozymes shares. The filing references tax withholding.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$19,427
Shares × reported transaction price
Closed at $5.05 on Oct 12, 2026, 15% above its 52-week low and 69% below its high, after a 30% drop over the previous 30 trading days
52-week range $4.40 (Jul 28, 2026) to $16.50 (Nov 12, 2025), 5% of the way up, from 244 adjusted closes. 30 trading days earlier: $7.17 on Aug 28, 2026. Describes the past only, not a forecast
Footnote references tax withholding
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +25.0% | −2.0% | +27.0% |
Past results only. Not a forecast.
Insider filing
Traded Oct 9 · filed 17 days later
Derivative exercise or conversion — not an open-market buy.
Insider filing
Traded Oct 9 · filed 17 days later
Derivative exercise or conversion — not an open-market buy.
Insider filing
Traded Oct 1 · filed 18 days later
Compensation award — excluded from discretionary-purchase analysis.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.